Tags

Type your tag names separated by a space and hit enter

Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Pediatr Infect Dis J. 2008 Jul; 27(7):595-601.PI

Abstract

BACKGROUND

Since the 1980s, Shiga toxin-producing Escherichia coli (STEC), especially E. coli O157:H7, has been an important cause of food borne disease in industrial countries. In France, as there was no routine screening for STEC in clinical laboratories, enhanced surveillance of hemolytic uremic syndrome (HUS) in children less than 15 years of age was established in 1996 to monitor trends in the incidence of STEC infections.

METHODS

The surveillance system was based on a voluntary national network of pediatricians of 31 pediatric nephrology units in public hospitals.

RESULTS

From 1996 to 2006, the mean annual incidence of HUS was 0.71 cases per 100,000 children less than 15 years of age and 1.87 cases per 100,000 children less than 5 years of age. STEC infections were confirmed in 66% of patients; STEC O157 was the most common serogroup identified in STEC-related HUS (83%). In this 11-year period, 96% of HUS cases were sporadic and only 2 outbreaks caused by STEC O157 and by a dual infection of STEC O26 and O80 were detected.

CONCLUSIONS

An evaluation of the surveillance of pediatric HUS showed that it is a simple and useful system for monitoring trends in STEC infections in France. It provides the information needed to measure the impact of new and changing vehicles of STEC transmission, and evaluate the effectiveness of prevention measures.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Espié E
Institut de Veille Sanitaire, Saint-Maurice, France. espie94@yahoo.fr
Grimont F
No affiliation info available
Mariani-Kurkdjian P
No affiliation info available
Bouvet P
No affiliation info available
Haeghebaert S
No affiliation info available
Filliol I
No affiliation info available
Loirat C
No affiliation info available
Decludt B
No affiliation info available
Minh NN
No affiliation info available
Vaillant V
No affiliation info available
de Valk H
No affiliation info available

MeSH

AdolescentChildChild, PreschoolComorbidityDisease OutbreaksEscherichia coli InfectionsFranceHemolytic-Uremic SyndromeHumansIncidenceInfantInfant, NewbornShiga-Toxigenic Escherichia coli

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18520972

Citation

Espié, Emmanuelle, et al. "Surveillance of Hemolytic Uremic Syndrome in Children Less Than 15 Years of Age, a System to Monitor O157 and non-O157 Shiga Toxin-producing Escherichia Coli Infections in France, 1996-2006." The Pediatric Infectious Disease Journal, vol. 27, no. 7, 2008, pp. 595-601.
Espié E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J. 2008;27(7):595-601.
Espié, E., Grimont, F., Mariani-Kurkdjian, P., Bouvet, P., Haeghebaert, S., Filliol, I., Loirat, C., Decludt, B., Minh, N. N., Vaillant, V., & de Valk, H. (2008). Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. The Pediatric Infectious Disease Journal, 27(7), 595-601. https://doi.org/10.1097/INF.0b013e31816a062f
Espié E, et al. Surveillance of Hemolytic Uremic Syndrome in Children Less Than 15 Years of Age, a System to Monitor O157 and non-O157 Shiga Toxin-producing Escherichia Coli Infections in France, 1996-2006. Pediatr Infect Dis J. 2008;27(7):595-601. PubMed PMID: 18520972.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. AU - Espié,Emmanuelle, AU - Grimont,Francine, AU - Mariani-Kurkdjian,Patricia, AU - Bouvet,Philippe, AU - Haeghebaert,Sylvie, AU - Filliol,Ingrid, AU - Loirat,Chantal, AU - Decludt,Bénédicte, AU - Minh,Nguyen Nhu Tran, AU - Vaillant,Véronique, AU - de Valk,Henriette, PY - 2008/6/4/pubmed PY - 2008/9/5/medline PY - 2008/6/4/entrez SP - 595 EP - 601 JF - The Pediatric infectious disease journal JO - Pediatr Infect Dis J VL - 27 IS - 7 N2 - BACKGROUND: Since the 1980s, Shiga toxin-producing Escherichia coli (STEC), especially E. coli O157:H7, has been an important cause of food borne disease in industrial countries. In France, as there was no routine screening for STEC in clinical laboratories, enhanced surveillance of hemolytic uremic syndrome (HUS) in children less than 15 years of age was established in 1996 to monitor trends in the incidence of STEC infections. METHODS: The surveillance system was based on a voluntary national network of pediatricians of 31 pediatric nephrology units in public hospitals. RESULTS: From 1996 to 2006, the mean annual incidence of HUS was 0.71 cases per 100,000 children less than 15 years of age and 1.87 cases per 100,000 children less than 5 years of age. STEC infections were confirmed in 66% of patients; STEC O157 was the most common serogroup identified in STEC-related HUS (83%). In this 11-year period, 96% of HUS cases were sporadic and only 2 outbreaks caused by STEC O157 and by a dual infection of STEC O26 and O80 were detected. CONCLUSIONS: An evaluation of the surveillance of pediatric HUS showed that it is a simple and useful system for monitoring trends in STEC infections in France. It provides the information needed to measure the impact of new and changing vehicles of STEC transmission, and evaluate the effectiveness of prevention measures. SN - 0891-3668 UR - https://www.unboundmedicine.com/medline/citation/18520972/Surveillance_of_hemolytic_uremic_syndrome_in_children_less_than_15_years_of_age_a_system_to_monitor_O157_and_non_O157_Shiga_toxin_producing_Escherichia_coli_infections_in_France_1996_2006_ L2 - https://doi.org/10.1097/INF.0b013e31816a062f DB - PRIME DP - Unbound Medicine ER -